Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1575 of 1958 entries
View as:

Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill")

Phase: N/A Priority: Normal
NCT ID: NCT00391118 Org: User:
Start: 11/30/06 End: 07/31/12 Due: 07/31/13

A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD)

Phase: N/A Priority: Normal
NCT ID: NCT06007651 Org: User:
Start: 08/10/23 End: 02/12/25 Due: 02/12/26

A Study of LY3154885 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04014361 Org: User:
Start: 08/09/19 End: 02/09/20 Due: 02/09/21

A Study of LY3337641 in Japanese and Caucasian Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03083561 Org: User:
Start: 03/15/17 End: 05/25/17 Due: 05/25/18

Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00191282 Org: User:
Start: 10/31/02 End: 10/31/07 Due: 10/31/08

A Study of LY3502970 in Participants With Normal and Impaired Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT05936138 Org: User:
Start: 07/13/23 End: 04/11/24 Due: 04/11/25

A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00913835 Org: User:
Start: 06/30/09 End: 02/28/14 Due: 02/28/15

Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT04250350 Org: User:
Start: 02/11/20 End: 06/22/22 Due: 06/22/23

A First Human Dose Study to Investigate Safety and Tolerability of LY2979165 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01248052 Org: User:
Start: 11/30/10 End: 05/31/11 Due: 05/31/12

A Study of LY3819253 (LY-CoV555) in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04537910 Org: User:
Start: 09/02/20 End: 12/28/20 Due: 12/28/21

A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00960986 Org: User:
Start: 08/31/09 End: 04/30/11 Due: 04/30/12

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hyperglycemic Medications (IOPE)

Phase: N/A Priority: Normal
NCT ID: NCT00510952 Org: User:
Start: 08/31/07 End: 10/31/08 Due: 10/31/09

A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction

Phase: N/A Priority: Normal
NCT ID: NCT01015287 Org: User:
Start: 12/31/09 End: 02/28/13 Due: 02/28/14

A Study of LY110140 in Healthy Japanese Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT01569126 Org: User:
Start: 04/30/12 End: 09/30/12 Due: 09/30/13

Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT01676701 Org: User:
Start: 09/30/12 End: 08/31/13 Due: 08/31/14

A Study of Multiple Doses of LY3305677 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03325387 Org: User:
Start: 10/27/17 End: 08/03/18 Due: 08/03/19

A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02450539 Org: User:
Start: 08/06/15 End: 07/29/20 Due: 07/29/21

A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00191490 Org: User:
Start: 07/31/02 End: 05/31/05 Due: 05/31/06

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT04238819 Org: User:
Start: 11/09/20 End: 04/30/25 Due: 04/30/26

A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight

Phase: N/A Priority: Normal
NCT ID: NCT06643728 Org: User:
Start: 10/21/24 End: 01/31/27 Due: 01/31/28

A Study of IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is Available

Phase: N/A Priority: Normal
NCT ID: NCT00785941 Org: User:
Start: 04/30/06 End: 11/30/07 Due: 11/30/08

A Study in Participants With Moderate to Severe Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01107457 Org: User:
Start: 04/30/10 End: 07/31/16 Due: 07/31/17

Lispro Mix 25 vs. Glargine in Type 2 Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT00551356 Org: User:
Start: 11/30/02 End: 07/31/03 Due: 07/31/04

A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00191607 Org: User:
Start: 07/31/02 End: 11/30/05 Due: 11/30/06

Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00329082 Org: User:
Start: 05/31/06 End: 05/31/08 Due: 05/31/09